Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Chronic sleep disorders and short-term sleep deprivation affect different regions of the brain, highlighting distinct neural ...

New research highlights that severe obstructive sleep apnea (OSA) independently predicts elevated C-reactive protein (CRP) ...

When Dr. Chris was first diagnosed with sleep apnea over 20 years ago, he had no idea how it would change the trajectory of ...

A new position statement from the American Academy of Sleep Medicine suggests clinicians should prioritize the evaluation and ...

Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.

About ResMed Inc. ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transfo ...